BOLT
Bolt Biotherapeutics Inc
$1.2
Earnings Summary
Revenue | $2.09Mn |
Net Profits | $-17.9Mn |
Net Profit Margins | -857.01% |
Highlights
Bolt Biotherapeutics Inc’s revenue jumped 48.05% since last year same period to $2.09Mn in the Q4 2023. On a quarterly growth basis, Bolt Biotherapeutics Inc has generated -17.37% fall in its revenue since last 3-months.
Bolt Biotherapeutics Inc’s net profit jumped 5.55% since last year same period to $-17.9Mn in the Q4 2023. On a quarterly growth basis, Bolt Biotherapeutics Inc has generated -10.12% fall in its net profits since last 3-months.
Bolt Biotherapeutics Inc’s net profit margin jumped 36.2% since last year same period to -857.01% in the Q4 2023. On a quarterly growth basis, Bolt Biotherapeutics Inc has generated -33.27% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Bolt Biotherapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | -0.51 |
EPS Estimate Current Year | -0.51 |
Highlights
Bolt Biotherapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.51 - a -6.25% fall from last quarter’s estimates.
Bolt Biotherapeutics Inc’s earning per share (EPS) estimates for the current year stand at -0.51.
Key Ratios
Key ratios of the Bolt Biotherapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | -0.47 |
Highlights
Bolt Biotherapeutics Inc’s earning per share (EPS) jumped 11.32% since last year same period to -0.47 in the Q4 2023. This indicates that the Bolt Biotherapeutics Inc has generated 11.32% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-05-11 | -0.51 | -0.45 | 11.76% |
2023-08-07 | -0.49 | -0.48 | 2.04% |
2024-03-21 | -0.48 | -0.47 | 2.08% |
2023-11-09 | -0.5 | -0.43 | 14% |
₹0 US Stocks a/c Opening Fee